home / stock / bysi / bysi news

BYSI News and Press, BeyondSpring Inc. From 01/11/24

Stock Information
Company Name: BeyondSpring Inc.
Stock Symbol: BYSI
Market: NASDAQ
Website: beyondspringpharma.com
Menu
BYSI BYSI Quote BYSI Short BYSI News BYSI Articles BYSI Message Board
Get BYSI Alerts

News, Short Squeeze, Breakout and More Instantly...
BYSI - BeyondSpring gets Nasdaq delinquency notice

2024-01-11 05:34:36 ET More on BeyondSpring Seeking Alpha’s Quant Rating on BeyondSpring Historical earnings data for BeyondSpring Financial information for BeyondSpring For further details see: BeyondSpring gets Nasdaq delinquency notice
BYSI - BeyondSpring Receives Nasdaq Delinquency Notice Regarding Late Filing of Its Form 6-K

NEW YORK, Jan. 10, 2024 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ: BYSI) (“BeyondSpring” or the “Company”), a global clinical-stage biopharmaceutical company focused on using a groundbreaking technology platform for drug discovery and developing innovative ...

BYSI - BeyondSpring receives Nasdaq notice regarding minimum bid price requirements

2023-12-18 16:37:43 ET More on BeyondSpring Seeking Alpha’s Quant Rating on BeyondSpring Historical earnings data for BeyondSpring Financial information for BeyondSpring For further details see: BeyondSpring receives Nasdaq notice regarding minimum...

BYSI - BeyondSpring Presents Poster Highlighting Preclinical and Clinical POC Immunomodulating Activity of Plinabulin Inducing Dendritic Cell Maturation and Re-sensitization in Immunotherapy Refractory Tumors when Combined with Radiation and PD-1/PD-L1 Inhibitor

New Clinical Data from MD Anderson Presented at the Society for Immunotherapy of Cancer’s 38 th Annual Meeting 80% DCR (disease control rate) in non-radiated tumor with Durable Responses in Heavily Pretreated Patients in 6 different cancers Full data was...
BYSI - BeyondSpring and Professor K. Eisenmann of the University of Toledo College of Medicine Present Poster Highlighting Plinabulin's Anti-cancer Efficacy in Primary and Recurrent Glioblastoma Patient Derived Invasive Neurosphere Models

NEW YORK, Oct. 31, 2023 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ: BYSI) (“BeyondSpring” or the “Company”), a global clinical-stage biopharmaceutical company focused on using a groundbreaking technology platform for drug discovery and developing innovative ...

BYSI - BeyondSpring regains compliance with Nasdaq minimum bid price rule

2023-10-30 11:26:55 ET More on BeyondSpring Seeking Alpha’s Quant Rating on BeyondSpring Historical earnings data for BeyondSpring Financial information for BeyondSpring For further details see: BeyondSpring regains compliance with Nasdaq minimum b...

BYSI - BeyondSpring Regains Compliance with Nasdaq Minimum Bid Price Requirement

NEW YORK, Oct. 30, 2023 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ: BYSI) (“BeyondSpring” or the “Company”), a global clinical-stage biopharmaceutical company focused on using a groundbreaking technology platform for drug discovery and developing innovative ...
BYSI - SEED Therapeutics Discloses Novel Molecular Glue IND Candidate for Cancer at "Targeted Protein Degradation Think Tank" Symposium

NEW YORK, Oct. 26, 2023 (GLOBE NEWSWIRE) -- SEED Therapeutics Inc. (“SEED”), a biotech company focused on harnessing and engineering Molecular Glues for targeted protein degradation (TPD) of disease-causing proteins, announced at its Monday, October 23, 2023 Targeted Protein Deg...

BYSI - MNTS, WHLR and PHIO among pre-market losers

2023-10-13 08:27:23 ET More on Momentus, Phio Pharmaceuticals, etc. Momentus Inc. (MNTS) Q2 2023 Earnings Call Transcript Wheeler REIT: Gearing Up For Sharemageddon Momentus to provide orbital delivery services for RIDE! Space Momentus prices $5M stock offeri...

BYSI - BeyondSpring and Leading Cancer Center to Present Poster at SITC's 38th Annual Meeting

NEW YORK, Sept. 27, 2023 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ: BYSI) (“BeyondSpring” or the “Company”), a global clinical-stage biopharmaceutical company focused on using a groundbreaking technology platform for drug discovery and developing innovative...
Previous 10 Next 10